We observed that somatic mutations in TP53 were significantly correlated with the CMP-pattern phenotype, whereas mutations in RUNX1, DNMT3A, BCOR and STAG2 were enriched in patients with GMP-pattern MDS (Fig. 1f). This evidence concerns the gene DNMT3A and myelodysplastic syndrome.